EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimodal MRI and 1H-MRS for Preoperative Stratification of High-Risk Molecular Subtype in Adult-Type Diffuse Gliomas

Xin Han, Kai Xiao, Jie Bai, Fengqi Li, Bixiao Cui, Ye Cheng, Huawei Liu, Jie Lu iD

Diagnostics · 15.11.2024 · 14 (22) · 2569

DOI: 10.3390/diagnostics14222569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 15.11.2024. Verfasst von Xin Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Huizhi Ascent Project of Xuanwu Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isocitrate dehydrogenase (IDH) and O6-methylguanine-DNA methyltransferase (MGMT) genes are critical molecular markers in determining treatment options and predicting the prognosis of adult-type diffuse gliomas. Objectives: this study aimed to investigate whether multimodal MRI enables the differentiation of genotypes in adult-type diffuse gliomas. Methods: a total of 116 adult-type diffuse glioma patients (61 males, 51.5 (37, 62) years old) who underwent multimodal MRI before surgery were retrospectively analysed. Multimodal MRI included conventional MRI, proton magnetic resonance spectroscopy (1H-MRS), and diffusion tensor imaging (DTI). Conventional visual features, N-acetyl-aspartate (NAA)/Creatine (Cr), Choline (Cho)/Cr, Cho/NAA, fractional anisotropy (FA), mean diffusivity (MD), and diffusion histogram parameters were extracted on the whole tumour. Multimodal MRI parameters of IDH-mutant and IDH-wildtype gliomas were compared using the Mann–Whitney U test, Student’s t-test, or Pearson chi-square tests. Logistic regression was used to select the MRI parameters to predict IDH-mutant gliomas. Furthermore, multimodal MRI parameters were selected to establish models for predicting MGMT methylation in the IDH-wildtype gliomas. The performance of models was evaluated by the receiver operating characteristics curve. Results: a total of 56 patients with IDH-mutant gliomas and 60 patients with IDH-wildtype glioblastomas (GBM) (37 with methylated MGMT and 17 with unmethylated MGMT) were diagnosed by 2021 WHO classification criteria. The enhancement degree (OR = 4.298, p < 0.001), necrosis/cyst (OR = 5.381, p = 0.011), NAA/Cr (OR = 0.497, p = 0.037), FA-Skewness (OR = 0.497, p = 0.033), MD-Skewness (OR = 1.849, p = 0.035), FAmean (OR = 1.924, p = 0.049) were independent factors for the multimodal combined prediction model in predicting IDH-mutant gliomas. The combined modal based on conventional MRI, 1H-MRS, DTI parameters, and histogram performed best in predicting IDH-wildtype status (AUC = 0.890). However, only NAA/Cr (OR = 0.17, p = 0.043) and FA (OR = 0.38, p = 0.015) were associated with MGMT methylated in IDH-wildtype GBM. The combination of NAA/Cr and FA-Median is more accurate for predicting MGMT methylation levels than using these elements alone (AUC, 0.847 vs. 0.695/0.684). Conclusions: multimodal MRI based on conventional MRI, 1H-MRS, and DTI can provide compound imaging markers for stratified individual diagnosis of IDH mutant and MGMT promoter methylation in adult-type diffuse gliomas.

Schlagwörter

Stichwörter der Autor:innen

O6-methylguanine DNA-methyltransferasediffusion tensor imaginggliomasisocitrate dehydrogenasemagnetic resonance spectroscopy

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
  • Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Capital Medical University, Beijing 100053, China.
  • Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
  • China Research & Scientific Affairs, GE Healthcare, Beijing 100176, China.

ORCID-Profile: Jie Lu

Förderung

  • National Key Research and Development Program of China
  • Huizhi Ascent Project of Xuanwu Hospital

Zitieren

APA

Han, X., Xiao, K., Bai, J., Li, F., Cui, B., Cheng, Y., Liu, H., & Lu, J. (2024). Multimodal MRI and 1H-MRS for Preoperative Stratification of High-Risk Molecular Subtype in Adult-Type Diffuse Gliomas. Diagnostics, 14(22), 2569. https://doi.org/10.3390/diagnostics14222569

Vancouver

Han X, Xiao K, Bai J, Li F, Cui B, Cheng Y, et al. Multimodal MRI and 1H-MRS for Preoperative Stratification of High-Risk Molecular Subtype in Adult-Type Diffuse Gliomas. Diagnostics. 2024;14(22):2569. doi:10.3390/diagnostics14222569

BibTeX
@article{Han2024,
  author = {Han, Xin and Xiao, Kai and Bai, Jie and Li, Fengqi and Cui, Bixiao and Cheng, Ye and Liu, Huawei and Lu, Jie},
  title = {Multimodal MRI and 1H-MRS for Preoperative Stratification of High-Risk Molecular Subtype in Adult-Type Diffuse Gliomas},
  journal = {Diagnostics},
  year = {2024},
  volume = {14},
  number = {22},
  pages = {2569},
  doi = {10.3390/diagnostics14222569}
}
Kostenlos starten →